TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.120
-0.010 (-0.47%)
Apr 29, 2026, 12:08 PM EDT - Market open
TuHURA Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 7.58 | 3.87 | 4.14 | 2.01 |
| Research & Development | 20.53 | 13.34 | 9.4 | 7.93 |
| Operating Expenses | 28.12 | 17.21 | 13.55 | 9.93 |
| Operating Income | -28.12 | -17.21 | -13.55 | -9.93 |
| Interest Expense | -0.63 | -4.14 | -0.02 | - |
| Interest & Investment Income | 0.14 | 0.36 | 0.09 | 0.06 |
| Other Non Operating Income (Expenses) | 0.71 | -0.26 | 0.04 | 0.21 |
| EBT Excluding Unusual Items | -27.89 | -21.24 | -13.43 | -9.66 |
| Merger & Restructuring Charges | -3.68 | -0.44 | - | - |
| Gain (Loss) on Sale of Investments | 1.59 | - | - | - |
| Other Unusual Items | -0.07 | - | 0.33 | 0.29 |
| Pretax Income | -30.05 | -21.68 | -29.32 | -9.37 |
| Net Income | -30.05 | -21.68 | -29.32 | -9.37 |
| Preferred Dividends & Other Adjustments | 0.01 | 0.97 | - | - |
| Net Income to Common | -30.06 | -22.65 | -29.32 | -9.37 |
| Shares Outstanding (Basic) | 48 | 19 | 12 | - |
| Shares Outstanding (Diluted) | 48 | 19 | 12 | - |
| Shares Change (YoY) | 156.81% | 56.97% | - | - |
| EPS (Basic) | -0.63 | -1.21 | -2.47 | - |
| EPS (Diluted) | -0.63 | -1.21 | -2.47 | - |
| Free Cash Flow | -27.71 | -14.79 | -13.25 | -7.54 |
| Free Cash Flow Per Share | -0.58 | -0.79 | -1.11 | - |
| EBITDA | -28.05 | -17.09 | -13.37 | -9.56 |
| D&A For EBITDA | 0.07 | 0.12 | 0.18 | 0.37 |
| EBIT | -28.12 | -17.21 | -13.55 | -9.93 |
Source: S&P Capital IQ. Standard template.
Financial Sources.